33,216 Shares in UnitedHealth Group Incorporated $UNH Bought by ABN Amro Investment Solutions

ABN Amro Investment Solutions purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 33,216 shares of the healthcare conglomerate’s stock, valued at approximately $10,362,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the period. LFA Lugano Financial Advisors SA acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $25,000. Nova Wealth Management Inc. grew its stake in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after purchasing an additional 78 shares during the period. Finally, Anderson Financial Strategies LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $61,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 3.6%

NYSE:UNH opened at $339.18 on Thursday. The firm has a market cap of $307.25 billion, a price-to-earnings ratio of 17.70, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $622.83. The firm has a 50-day moving average price of $347.08 and a two-hundred day moving average price of $320.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the company earned $7.15 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is 46.14%.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Jefferies Financial Group increased their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. TD Cowen raised their target price on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Finally, Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.